Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma. (Q54457007)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

gestational choriocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

C J Brindley

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

P Antoniw

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

E S Newlands

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

K D Bagshawe

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

15

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

66-71

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

Pharmacokinetic principles of antineoplastic drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

STRIPE: an interactive computer program for the analysis of drug pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of commonly used anticancer drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumour activity of the epipodophyllin derivative VP16–213 (etoposide: NSC-141540) in gestational choriocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VP16-213 as a single agent in advanced testicular tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The practical benefits of pharmacokinetics in the use of antineoplastic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further advances in the management of malignant teratomas of the testis and other sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Forecasting individual pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo Metabolite-antimetabolite relationships in antitumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VP-16–213 salvage therapy for refractory germinal neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of VP16-213 given by different administration methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/4039984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00257298

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/4039984

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54457007&oldid=2212475418"